FDA Panel to Consider Two Cancer Drugs
WASHINGTON (MedPage Today) -- The FDA's Oncologic Drugs Advisory Committee will meet Thursday to weigh the approval evidence for two cancer therapies: tivozanib and a drug-device product combining melphalan (Alkeran) with a novel infusion kit.